Navigation Links
Alzheimer's found to be mostly genetic

Alzheimer disease has a genetic cause in up to 80 percent of cases, according to a University of Southern California-led study of nearly 12,000 twin pairs.

The study appears in the February 2006 issue of Archives of General Psychiatry, a journal of the American Medical Association.

Margaret Gatz, professor of psychology in the USC College of Letters, Arts, and Sciences, led an international team of researchers from Göteborg University, Jönköping University and Karolinska Institutet in Sweden, as well as from USC, the University of California at Riverside and the University of South Florida.

Past estimates of Alzheimer's risk varied widely, with the highest numbers sometimes greeted with skepticism.

"Our finding confirms the higher estimates that have been suggested previously. The important thing is that no one has had this large a sample before," Gatz said, adding the size was 10 times that of any previous study.

The study raises doubts about the widely held view that Alzheimer's has two forms: the "familial," with genetic roots, and the "sporadic," with environmental causes.

"In essence what we're doing is taking the folks who would have formerly been called sporadic, and testing how important genetic influences are ... and we're finding genetic influences are tremendously important," Gatz said."It does suggest that there is an underlying genetic basis."

Gatz warned, "This doesn't mean that environment is not important. Environment may be relevant not only for whether but also for when one gets the disease. Also, you can't go from these results to any one individual."

Even identical twins, who share all their genes, differ in their vulnerability. The study found only a 45 percent concordance rate for identical male pairs. This means that of all pairs where one twin has Alzheimer's, 55 percent of the healthy twins either will never get the disease or will develop it later in life.

In her previo us research with twins, Gatz identified possible preventive or delaying factors, such as a low incidence of inflammatory disease or a work environment with a high degree of human interaction.

The sample for the study consisted of all participants in the Swedish Twin Registry aged 65 or older in 1998 - the year the study began -- for a total of 11,884 twin pairs.

Of these, 392 pairs showed evidence of Alzheimer's in at least one twin.

In the model that best fit the data, genetic influence accounted for 79 percent of Alzheimer's risk, with 95percent confidence in a range of 67 to 88 percent.

The other 21 percent of Alzheimer's risk was due to non-shared environmental causes. Risk from shared environments, such as childhood settings that were the same for both twins, was statistically negligible.

Genetic risk for Alzheimer's was the same for men and women after controlling for age.

The study is notable for its careful approach to Alzheimer's diagnosis. All individuals were screened for cognitive dysfunction. Suspected cases of dementia, of which Alzheimer's is the most common form, received complete, in-home clinical diagnostic evaluations by a doctor and nurse. Autopsy confirmation of diagnoses is being collected.

The research for this study was supported by grants from the National Institute on Aging and the Alzheimer's Association.

The other USC researcher on the study was co-principal investigator Nancy Pedersen, a research professor with ajoint appointment as professor at Karolinska Institutet.


Source:University of Southern California

Related biology news :

1. Neuronal traffic jam marks early Alzheimers disease
2. Mouse brain cells rapidly recover after Alzheimers plaques are cleared
3. Gene vaccine for Alzheimers disease shows promising results
4. Duke Chemists Isolating Individual Molecules Of Toxic Protein In Alzheimers, Parkinsons Disease
5. Nanoscale Diagnostic Sets Sights on Alzheimers
6. Alzheimers cognitive decline slowed
7. One gene links newborn neurons with those that die in diseases such as Alzheimers
8. Scientists discover that three molecules may be developed into new Alzheimers drugs
9. Pinpointing a culprit molecule in Alzheimers disease
10. Targeting a key enzyme with gene therapy reversed course of Alzheimers disease in mouse models
11. Hope for Alzheimers blossoms
Post Your Comments:

(Date:10/29/2015)... , Oct. 29, 2015   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... High Tech Association (MHTA) as one of only three ... the "Software – Small and Growing" category. The Tekne Awards ... who have shown superior technology innovation and leadership. ...
(Date:10/29/2015)... 29, 2015  Rubicon Genomics, Inc., today announced ... of its DNA library preparation products, including the ... ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been optimized ... NGS libraries for liquid biopsies--the analysis of cell-free ... applications in cancer and other conditions. Eurofins Scientific ...
(Date:10/29/2015)... , Oct. 29, 2015 Today, ... a partnership with 2XU, a global leader in ... a smart hat with advanced bio-sensing technology. The ... athletes to monitor key biometrics to improve overall ... partnership, the two companies will bring together the most ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... , November 26, 2015 ... Biobanking Market 2016 - 2020 report analyzes that ... integrity and quality in long-term samples, minimizing manual ... cost-effectiveness. Automation minimizes manual errors such as mislabeling ... efficiency. Further, it plays a vital role in ...
(Date:11/25/2015)... -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today ... Neurocrine Biosciences, will be presenting at the 27th Annual ... . .   Listeners ... prior to the presentation to download or install any ... available on the website approximately one hour after the ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and ... early in their initial angel funding process. Now, they are paying it forward ... make early stage investments in the microbiome space. In this, they join ...
(Date:11/24/2015)... 24, 2015 /CNW/ - iCo Therapeutics ("iCo" or "the ... results for the quarter ended September 30, 2015. ... dollars and presented under International Financial Reporting Standards ... ," said Andrew Rae , President & ... are not only value enriching for this clinical ...
Breaking Biology Technology: